nodes	percent_of_prediction	percent_of_DWPC	metapath
Budesonide—Stridor—Riluzole—amyotrophic lateral sclerosis	0.0384	0.0388	CcSEcCtD
Budesonide—Osteonecrosis—Riluzole—amyotrophic lateral sclerosis	0.0336	0.034	CcSEcCtD
Budesonide—Osteoporosis—Riluzole—amyotrophic lateral sclerosis	0.0223	0.0226	CcSEcCtD
Budesonide—Oral candidiasis—Riluzole—amyotrophic lateral sclerosis	0.0197	0.0199	CcSEcCtD
Budesonide—Tooth disorder—Riluzole—amyotrophic lateral sclerosis	0.0193	0.0195	CcSEcCtD
Budesonide—Intestinal obstruction—Riluzole—amyotrophic lateral sclerosis	0.0184	0.0186	CcSEcCtD
Budesonide—Metrorrhagia—Riluzole—amyotrophic lateral sclerosis	0.0175	0.0177	CcSEcCtD
Budesonide—Glaucoma—Riluzole—amyotrophic lateral sclerosis	0.0166	0.0168	CcSEcCtD
Budesonide—Abscess—Riluzole—amyotrophic lateral sclerosis	0.0158	0.016	CcSEcCtD
Budesonide—Endocrine disorder—Riluzole—amyotrophic lateral sclerosis	0.0151	0.0153	CcSEcCtD
Budesonide—Bone disorder—Riluzole—amyotrophic lateral sclerosis	0.0139	0.014	CcSEcCtD
Budesonide—Cough increased—Riluzole—amyotrophic lateral sclerosis	0.0137	0.0138	CcSEcCtD
Budesonide—Glossitis—Riluzole—amyotrophic lateral sclerosis	0.0136	0.0137	CcSEcCtD
Budesonide—Nocturia—Riluzole—amyotrophic lateral sclerosis	0.0135	0.0136	CcSEcCtD
Budesonide—Leukocytosis—Riluzole—amyotrophic lateral sclerosis	0.0133	0.0135	CcSEcCtD
Budesonide—Ulcer—Riluzole—amyotrophic lateral sclerosis	0.0132	0.0134	CcSEcCtD
Budesonide—Cataract—Riluzole—amyotrophic lateral sclerosis	0.0132	0.0133	CcSEcCtD
Budesonide—Neck pain—Riluzole—amyotrophic lateral sclerosis	0.0127	0.0128	CcSEcCtD
Budesonide—Phosphatase alkaline increased—Riluzole—amyotrophic lateral sclerosis	0.0125	0.0126	CcSEcCtD
Budesonide—Dermatitis contact—Riluzole—amyotrophic lateral sclerosis	0.0124	0.0125	CcSEcCtD
Budesonide—Candida infection—Riluzole—amyotrophic lateral sclerosis	0.012	0.0121	CcSEcCtD
Budesonide—Fluid retention—Riluzole—amyotrophic lateral sclerosis	0.0119	0.012	CcSEcCtD
Budesonide—Ecchymosis—Riluzole—amyotrophic lateral sclerosis	0.0113	0.0114	CcSEcCtD
Budesonide—Hypertonia—Riluzole—amyotrophic lateral sclerosis	0.011	0.0111	CcSEcCtD
Budesonide—Ear pain—Riluzole—amyotrophic lateral sclerosis	0.0107	0.0108	CcSEcCtD
Budesonide—Lymphadenopathy—Riluzole—amyotrophic lateral sclerosis	0.0107	0.0108	CcSEcCtD
Budesonide—Blood alkaline phosphatase increased—Riluzole—amyotrophic lateral sclerosis	0.0105	0.0106	CcSEcCtD
Budesonide—Vascular purpura—Riluzole—amyotrophic lateral sclerosis	0.0102	0.0103	CcSEcCtD
Budesonide—Eczema—Riluzole—amyotrophic lateral sclerosis	0.0101	0.0102	CcSEcCtD
Budesonide—Increased appetite—Riluzole—amyotrophic lateral sclerosis	0.00968	0.00977	CcSEcCtD
Budesonide—Amnesia—Riluzole—amyotrophic lateral sclerosis	0.00968	0.00977	CcSEcCtD
Budesonide—Thirst—Riluzole—amyotrophic lateral sclerosis	0.00955	0.00965	CcSEcCtD
Budesonide—Purpura—Riluzole—amyotrophic lateral sclerosis	0.00943	0.00953	CcSEcCtD
Budesonide—Arthritis—Riluzole—amyotrophic lateral sclerosis	0.00935	0.00945	CcSEcCtD
Budesonide—Affect lability—Riluzole—amyotrophic lateral sclerosis	0.00895	0.00904	CcSEcCtD
Budesonide—Migraine—Riluzole—amyotrophic lateral sclerosis	0.00895	0.00904	CcSEcCtD
Budesonide—Psychotic disorder—Riluzole—amyotrophic lateral sclerosis	0.00888	0.00897	CcSEcCtD
Budesonide—Face oedema—Riluzole—amyotrophic lateral sclerosis	0.00878	0.00886	CcSEcCtD
Budesonide—Mood swings—Riluzole—amyotrophic lateral sclerosis	0.00861	0.0087	CcSEcCtD
Budesonide—Hypokalaemia—Riluzole—amyotrophic lateral sclerosis	0.00827	0.00836	CcSEcCtD
Budesonide—Breast disorder—Riluzole—amyotrophic lateral sclerosis	0.00822	0.0083	CcSEcCtD
Budesonide—Abdominal distension—Riluzole—amyotrophic lateral sclerosis	0.00791	0.00799	CcSEcCtD
Budesonide—Influenza—Riluzole—amyotrophic lateral sclerosis	0.00786	0.00794	CcSEcCtD
Budesonide—Bronchitis—Riluzole—amyotrophic lateral sclerosis	0.00756	0.00763	CcSEcCtD
Budesonide—Dysuria—Riluzole—amyotrophic lateral sclerosis	0.00735	0.00742	CcSEcCtD
Budesonide—Pollakiuria—Riluzole—amyotrophic lateral sclerosis	0.00726	0.00733	CcSEcCtD
Budesonide—Fluocinolone Acetonide—PLA2G4A—amyotrophic lateral sclerosis	0.0072	0.732	CrCbGaD
Budesonide—Weight increased—Riluzole—amyotrophic lateral sclerosis	0.00715	0.00722	CcSEcCtD
Budesonide—Infestation—Riluzole—amyotrophic lateral sclerosis	0.00701	0.00708	CcSEcCtD
Budesonide—Infestation NOS—Riluzole—amyotrophic lateral sclerosis	0.00701	0.00708	CcSEcCtD
Budesonide—Urinary tract infection—Riluzole—amyotrophic lateral sclerosis	0.00681	0.00688	CcSEcCtD
Budesonide—Haematuria—Riluzole—amyotrophic lateral sclerosis	0.00668	0.00675	CcSEcCtD
Budesonide—Epistaxis—Riluzole—amyotrophic lateral sclerosis	0.00661	0.00667	CcSEcCtD
Budesonide—Sinusitis—Riluzole—amyotrophic lateral sclerosis	0.00657	0.00664	CcSEcCtD
Budesonide—Haemoglobin—Riluzole—amyotrophic lateral sclerosis	0.00632	0.00638	CcSEcCtD
Budesonide—Rhinitis—Riluzole—amyotrophic lateral sclerosis	0.00631	0.00637	CcSEcCtD
Budesonide—Haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.00629	0.00635	CcSEcCtD
Budesonide—Pharyngitis—Riluzole—amyotrophic lateral sclerosis	0.00624	0.0063	CcSEcCtD
Budesonide—Urinary tract disorder—Riluzole—amyotrophic lateral sclerosis	0.00621	0.00627	CcSEcCtD
Budesonide—Oedema peripheral—Riluzole—amyotrophic lateral sclerosis	0.0062	0.00626	CcSEcCtD
Budesonide—Connective tissue disorder—Riluzole—amyotrophic lateral sclerosis	0.00618	0.00624	CcSEcCtD
Budesonide—Urethral disorder—Riluzole—amyotrophic lateral sclerosis	0.00617	0.00623	CcSEcCtD
Budesonide—Eye disorder—Riluzole—amyotrophic lateral sclerosis	0.00588	0.00594	CcSEcCtD
Budesonide—Cardiac disorder—Riluzole—amyotrophic lateral sclerosis	0.00584	0.00589	CcSEcCtD
Budesonide—Angiopathy—Riluzole—amyotrophic lateral sclerosis	0.00571	0.00576	CcSEcCtD
Budesonide—Immune system disorder—Riluzole—amyotrophic lateral sclerosis	0.00568	0.00574	CcSEcCtD
Budesonide—Mediastinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00567	0.00572	CcSEcCtD
Budesonide—Alopecia—Riluzole—amyotrophic lateral sclerosis	0.00556	0.00561	CcSEcCtD
Budesonide—Mental disorder—Riluzole—amyotrophic lateral sclerosis	0.00551	0.00556	CcSEcCtD
Budesonide—Malnutrition—Riluzole—amyotrophic lateral sclerosis	0.00547	0.00553	CcSEcCtD
Budesonide—Flatulence—Riluzole—amyotrophic lateral sclerosis	0.00539	0.00545	CcSEcCtD
Budesonide—Tension—Riluzole—amyotrophic lateral sclerosis	0.00537	0.00543	CcSEcCtD
Budesonide—Dysgeusia—Riluzole—amyotrophic lateral sclerosis	0.00536	0.00541	CcSEcCtD
Budesonide—Nervousness—Riluzole—amyotrophic lateral sclerosis	0.00532	0.00537	CcSEcCtD
Budesonide—Back pain—Riluzole—amyotrophic lateral sclerosis	0.0053	0.00535	CcSEcCtD
Budesonide—Muscle spasms—Riluzole—amyotrophic lateral sclerosis	0.00526	0.00532	CcSEcCtD
Budesonide—Tremor—Riluzole—amyotrophic lateral sclerosis	0.00513	0.00518	CcSEcCtD
Budesonide—Ill-defined disorder—Riluzole—amyotrophic lateral sclerosis	0.00508	0.00513	CcSEcCtD
Budesonide—Anaemia—Riluzole—amyotrophic lateral sclerosis	0.00506	0.00511	CcSEcCtD
Budesonide—Agitation—Riluzole—amyotrophic lateral sclerosis	0.00503	0.00508	CcSEcCtD
Budesonide—Angioedema—Riluzole—amyotrophic lateral sclerosis	0.005	0.00505	CcSEcCtD
Budesonide—Malaise—Riluzole—amyotrophic lateral sclerosis	0.00494	0.00499	CcSEcCtD
Budesonide—Vertigo—Riluzole—amyotrophic lateral sclerosis	0.00492	0.00497	CcSEcCtD
Budesonide—Syncope—Riluzole—amyotrophic lateral sclerosis	0.00491	0.00496	CcSEcCtD
Budesonide—Palpitations—Riluzole—amyotrophic lateral sclerosis	0.00484	0.00489	CcSEcCtD
Budesonide—Loss of consciousness—Riluzole—amyotrophic lateral sclerosis	0.00481	0.00486	CcSEcCtD
Budesonide—Cough—Riluzole—amyotrophic lateral sclerosis	0.00478	0.00482	CcSEcCtD
Budesonide—Hypertension—Riluzole—amyotrophic lateral sclerosis	0.00473	0.00477	CcSEcCtD
Budesonide—Arthralgia—Riluzole—amyotrophic lateral sclerosis	0.00466	0.00471	CcSEcCtD
Budesonide—Myalgia—Riluzole—amyotrophic lateral sclerosis	0.00466	0.00471	CcSEcCtD
Budesonide—Chest pain—Riluzole—amyotrophic lateral sclerosis	0.00466	0.00471	CcSEcCtD
Budesonide—Anxiety—Riluzole—amyotrophic lateral sclerosis	0.00464	0.00469	CcSEcCtD
Budesonide—Unspecified disorder of skin and subcutaneous tissue—Riluzole—amyotrophic lateral sclerosis	0.00463	0.00467	CcSEcCtD
Budesonide—Discomfort—Riluzole—amyotrophic lateral sclerosis	0.00461	0.00465	CcSEcCtD
Budesonide—Dry mouth—Riluzole—amyotrophic lateral sclerosis	0.00456	0.0046	CcSEcCtD
Budesonide—Confusional state—Riluzole—amyotrophic lateral sclerosis	0.00451	0.00455	CcSEcCtD
Budesonide—Anaphylactic shock—Riluzole—amyotrophic lateral sclerosis	0.00447	0.00451	CcSEcCtD
Budesonide—Infection—Riluzole—amyotrophic lateral sclerosis	0.00444	0.00448	CcSEcCtD
Budesonide—Shock—Riluzole—amyotrophic lateral sclerosis	0.0044	0.00444	CcSEcCtD
Budesonide—Nervous system disorder—Riluzole—amyotrophic lateral sclerosis	0.00438	0.00443	CcSEcCtD
Budesonide—Tachycardia—Riluzole—amyotrophic lateral sclerosis	0.00436	0.0044	CcSEcCtD
Budesonide—Skin disorder—Riluzole—amyotrophic lateral sclerosis	0.00434	0.00438	CcSEcCtD
Budesonide—Hyperhidrosis—Riluzole—amyotrophic lateral sclerosis	0.00432	0.00436	CcSEcCtD
Budesonide—Anorexia—Riluzole—amyotrophic lateral sclerosis	0.00426	0.0043	CcSEcCtD
Budesonide—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00407	0.00411	CcSEcCtD
Budesonide—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.00404	0.00408	CcSEcCtD
Budesonide—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.00401	0.00405	CcSEcCtD
Budesonide—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.00398	0.00402	CcSEcCtD
Budesonide—Somnolence—Riluzole—amyotrophic lateral sclerosis	0.00397	0.00401	CcSEcCtD
Budesonide—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.00393	0.00397	CcSEcCtD
Budesonide—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.00388	0.00392	CcSEcCtD
Budesonide—Gastrointestinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00386	0.0039	CcSEcCtD
Budesonide—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.00385	0.00389	CcSEcCtD
Budesonide—Constipation—Riluzole—amyotrophic lateral sclerosis	0.00382	0.00386	CcSEcCtD
Budesonide—Pain—Riluzole—amyotrophic lateral sclerosis	0.00382	0.00386	CcSEcCtD
Budesonide—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.00368	0.00372	CcSEcCtD
Budesonide—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.00365	0.00369	CcSEcCtD
Budesonide—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.00355	0.00358	CcSEcCtD
Budesonide—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.00353	0.00357	CcSEcCtD
Budesonide—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.00353	0.00357	CcSEcCtD
Budesonide—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.00329	0.00332	CcSEcCtD
Budesonide—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.00321	0.00324	CcSEcCtD
Budesonide—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.00316	0.00319	CcSEcCtD
Budesonide—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.00306	0.00309	CcSEcCtD
Budesonide—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.00295	0.00298	CcSEcCtD
Budesonide—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.00284	0.00287	CcSEcCtD
Budesonide—Rash—Riluzole—amyotrophic lateral sclerosis	0.00282	0.00285	CcSEcCtD
Budesonide—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.00281	0.00284	CcSEcCtD
Budesonide—Headache—Riluzole—amyotrophic lateral sclerosis	0.0028	0.00283	CcSEcCtD
Budesonide—Nausea—Riluzole—amyotrophic lateral sclerosis	0.00265	0.00268	CcSEcCtD
Budesonide—Triamcinolone—PTGS2—amyotrophic lateral sclerosis	0.00115	0.117	CrCbGaD
Budesonide—Betamethasone—PTGS2—amyotrophic lateral sclerosis	0.00094	0.0956	CrCbGaD
Budesonide—Dexamethasone—PTGS2—amyotrophic lateral sclerosis	0.000547	0.0556	CrCbGaD
